TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.40nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.40nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.40nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of LSD1 (unknown origin) using H3K4me1 substrate by TR-FRET assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 73nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of LSD1 in human THP1 cells assessed as induction of cell differentiation by measuring CD11b expression incubated for 96 hrs by FACS assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of human ERG expressed in HEK293 cells by patch clamp assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataEC50: 3nMAssay Description:Inhibition of LSD1 in human NCI-H69 cells assessed as suppression of GRP mRNA expression incubated for 4 days by qPCR analysisMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataEC50: 4nMAssay Description:Inhibition of LSD1 in human NCI-H1417 cells assessed as suppression of GRP mRNA expression incubated for 4 days by qPCR analysisMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Fount Therapeutics
Curated by ChEMBL
Fount Therapeutics
Curated by ChEMBL
Affinity DataEC50: 6nMAssay Description:Inhibition of LSD1 in human NCI-H1417 cells assessed as suppression of GRP mRNA expression incubated for 12 days by qPCR analysisMore data for this Ligand-Target Pair